Coeptis Therapeutics, Inc. — Regulation A 1-A

Coeptis Therapeutics, Inc. of WEXFORD, PA filed a Regulation A 1-A with the SEC on 2021-11-18. Aggregate offering: $12.0M (Tier 2). Industry: Other.

Offering

• Filed: 2021-11-18
• Form: 1-A
• Accession: 0001683168-21-005805
• Tier: Tier 2
• Total aggregate offering: $12.0M
• Issuer portion: $12.0M
• Price per security: $4.0000
• Securities offered: Equity (common or preferred stock)
• Audit status: Audited
• Auditor: Turner, Stone & Company, LLP
• Jurisdictions: 64 states/territories

Issuer

• CIK: 0001819663
• Organized in: DE
• Incorporated: 1996
• Address: 105 BRADFORD RD, SUITE 420, WEXFORD, PA, 15090
• Phone: 724-934-6467
• Employees: 4 full-time, 1 part-time

Financial snapshot (as filed)

• Total assets: $7.7M
• Cash & equivalents: $2.8M
• Total liabilities: $7.1M
• Stockholder equity: $573K
• Revenues: $75K
• Net income: $-10.6M

People (1)

More

• CIK 1819663 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search